Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Various cytoskeletal proteins have been implicated in the cellular pathology of Alzheimer's disease. A monoclonal antibody (SMI32) that recognizes nonphosphorylated epitopes on the medium (168 kDa) and heavy (200 kDa) subunits of neurofilament proteins has been used to label and analyze a specific subpopulation of pyramidal neurons in the prefrontal and inferior temporal cortices of normal and Alzheimer's disease brains. In Alzheimer's disease, the distribution of neuropathological markers predominates in layers III and V in these association areas. In these neocortical regions, SMI32 primarily labels the perikarya and dendrites of large pyramidal neurons, predominantly located within layers III and V. In Alzheimer's disease, a dramatic loss of SMI32-immunoreactive (ir) cells was observed, affecting particularly the largest cells (i.e., cells with a cross-sectional perikaryal area larger than 350 microns 2). The staining intensity of the largest SMI32-ir neurons was significantly reduced in Alzheimer's disease cases, suggesting that an inappropriate phosphorylation of these cytoskeletal proteins may take place in the course of the pathological process. In addition, the SMI32-ir neuron loss and total neuron loss were highly correlated with neurofibrillary tangle counts, whereas such a correlation was not observed with neuritic plaque counts. These quantitative data suggest that SMI32-ir neurons represent a small subset of pyramidal cells that share certain anatomical and molecular characteristics and are highly vulnerable in Alzheimer's disease. Other studies have suggested that SMI32-ir neurons are likely to furnish long corticocortical projections. Thus, their loss would substantially diminish the effectiveness of the distributed processing capacity of the neocortex, resulting in a neocortical isolation syndrome as reflected by the clinical symptomatology observed in these patients. Such correlations between the expression of a selective cellular pathology and specific elements of cortical circuitry will increase our understanding of the molecular and cellular characteristics underlying a given neuronal subclass vulnerability in Alzheimer's disease or other neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neuron loss is a basic and fundamental feature in the pathogenesis of AD [18,19], starting already at preclinical stages when the neuropathological hallmarks are not yet present [20].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [19]
In the citing paper
“For example, there was a selective loss of excitatory neurons in the supragranular layers (L2/3 IT)9,54.”
From Integrated multimodal cell atlas of Alzheimer’s disease (2024) · cites this paper as [54]
In the citing paper
“In humans, neurons in the prefrontal cortex with specialization such as these exhibit enhanced susceptibility to neurodegeneration in the course of disorders like Alzheimer’s disease (31–34).”
From Evolution of increased glia–neuron ratios in the human frontal cortex (2006) · cites this paper as [33]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Circuitry of Primate Prefrontal Cortex and Regulation of Behavior by Representational Memory
Goldman‐Rakic, P. S. (1987) · Comprehensive Physiology · doi:10.1002/cphy.cp010509 · Cited by 1,960
AN ANATOMICAL STUDY OF CONVERGING SENSORY PATHWAYS WITHIN THE CEREBRAL CORTEX OF THE MONKEY
JONES, E. G., & POWELL, T. P. S. (1970) · Brain · doi:10.1093/brain/93.4.793 · Cited by 1,711
Topography of Cognition: Parallel Distributed Networks in Primate Association Cortex
Goldman-Rakic, P. S. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.001033 · Cited by 1,660
Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988) · Annals of Neurology · doi:10.1002/ana.410230206 · Cited by 1,225
Sternberger, L. A., & Sternberger, N. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6126 · Cited by 1,158
The functional logic of cortical connections
Zeki, S., & Shipp, S. (1988) · Nature · doi:10.1038/335311a0 · Cited by 1,067
Principles of behavioral neurology
Mesulam, M. M. (1985) · Davis eBooks · Cited by 991
Research works printed but not linked: 7
- Campbell M. J., 1989, A subset of primate corticocortical neurons are neurofilament protein (NFP) immunoreactive (ir): a combined retrograde immunohistochemical study, Proc. Soc. Neurosci., 15, 72
- Gambetti P., 1987, Neurochemistry of Aging, 309
- Goldman‐Rakic P. S., 1987, Handbook of Physiology, 373
- Hof P. R., 1988, Quantitative analysis of non‐phosphorylated neurofilament protein (NPNFP)‐immunoreactive neurons in normal and Alzheimer's disease brain, Proc. Soc. Neurosci., 14, 1086
- Morrison J. H., 1986, The Biological Substrates of Alzheimer's Disease, UCLA Forum in Medical Sciences, 115
- Morrison J. H., 1987, Molecular Neuropathology of Aging. Banbury Report, 109
- Rapoport S. I., 1987, Molecular Neuropathology of Aging, Banbury Report, 37
Cited by
Items 101–200 of 366
Barone, P., Dehay, C., Berland, M., & Kennedy, H. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961007)374:1<1::aid-cne1>3.0.co;2-7 · Cited by 64
Self-citationGiannakopoulos, P., Hof, P. R., Mottier, S., Michel, J., & Bouras, C. (1994) · Acta Neuropathologica · doi:10.1007/bf00294172 · Cited by 110
“In this respect, the strong correlation between the presence of these lesions in anatomically linked regions (hippocampus, temporal and frontal neocortex) in SDAT cases of this series is very interesting, since several authors proposed that the degenerative process involves select corticocortical circuits [30, 31, 36,…”
BackgroundSelf-citationPathological Substrates of Cognitive Decline in Alzheimer’s Disease
Giannakopoulos, P., Kövari, E., Gold, G., von Gunten, A., Hof, P. R., & Bouras, C. (2009) · Frontiers of Neurology and Neuroscience · doi:10.1159/000197881 · Cited by 101
Self-citationRebrin, I., Forster, M. J., & Sohal, R. S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.10.040 · Cited by 114
“For example, losses of certain cognitive functions, in both aging and in Alzheimer's disease, involve the cerebral cortex, cortical inputs to the hippocampus, and the hippocampus proper (Hyman et al., 1984; Hof et al., 1990; Geinisman et al., 1995; Morrison and Hof, 1997).”
BackgroundCognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease
GUNTEN, A., KOVARI, E., BUSSIERE, T., RIVARA, C., GOLD, G., BOURAS, C., HOF, P., & GIANNAKOPOULOS, P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.008 · Cited by 101
Wang, M., Song, W., Chen, M., Wang, Q., Zhou, X., Xu, P., Krek, A., Yoon, Y., Ho, L., Orr, M. E., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00517-z · Cited by 110
Amygdala cell loss and atrophy in Alzheimer's disease
Scott, S. A., Sparks, D. L., Scheff, S. W., Dekosky, S. T., & Knox, C. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320412 · Cited by 100
Kabaso, D., Coskren, P. J., Henry, B. I., Hof, P. R., & Wearne, S. L. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn242 · Cited by 98
Self-citationMatthews, D. C., Mao, X., Dowd, K., Tsakanikas, D., Jiang, C. S., Meuser, C., Andrews, R. D., Lukic, A. S., Lee, J., Hampilos, N., et al. (2021) · Brain · doi:10.1093/brain/awab222 · Cited by 97
Heterogeneity of layer II neurons in human entorhinal cortex
Beall, M. J., & Lewis, D. A. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903210206 · Cited by 97
Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease
Vickers, J. C., Delacourte, A., & Morrison, J. H. (1992) · Brain Research · doi:10.1016/0006-8993(92)91134-z · Cited by 99
Self-citationTemporal Sequence of Alzheimer’s Disease-Related Pathology
Braak, H., & Braak, E. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_14 · Cited by 104
Functional Genomics of Brain Aging and Alzheimers Disease: Focus on Selective Neuronal Vulnerability
Wang, X., L. Michaelis, M., & K. Michaelis, E. (2010) · Current Genomics · doi:10.2174/138920210793360943 · Cited by 93
“pyramidal neurons in the areas mentioned above, particularly association neurons with long projections [61, 62].”
BackgroundVoelker, C. C. J. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh089 · Cited by 92
Vickers, J. C., & Costa, M. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90077-f · Cited by 91
The synaptic organization of the neocortex in Alzheimer's disease
Masliah, E., Miller, A., & Terry, R. D. (1993) · Medical Hypotheses · doi:10.1016/0306-9877(93)90078-5 · Cited by 96
Masliah, E., Mallory, M. E., Hansen, L. A., Alford, M. F., DeTeresa, R. M., Terry, R. D., Baudier, J., & Saitoh, T. (1992) · Brain Research · doi:10.1016/0006-8993(92)90831-s · Cited by 96
Structural networks in Alzheimer's disease
Reid, A., & Evans, A. C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.11.010 · Cited by 98
“’’ They suggest that NFTs selectively occur within large pyramidal cells which give rise to long-range corticocortical projections, a proposition which has since been confirmed by quantitative analyses in superior frontal, inferotemporal, and primary and secondary visual cortex (Hof et al., 1990; Hof and Morrison, 199…”
ResultMorrison, B. M., Gordon, J. W., Ripps, M. E., & Morrison, J. H. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960930)373:4<619::aid-cne9>3.0.co;2-4 · Cited by 89
Self-citationFonseca, M., Soriano, E., Ferrer, I., Martínez, A., & Tun˜on, T. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90324-9 · Cited by 92
Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders
Yuan, A., & Nixon, R. A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.09.002 · Cited by 85
“In this regard, Morrison and colleagues reported that, certain populations of cortico-cortical pyramidal neurons that contain abundant perikaryal NF in relatively low states of phosphorylation are highly vulnerable to neurodegeneration through NFT formation [82, 83, 121, 178, 179].”
Kukreja, L., Kujoth, G. C., Prolla, T. A., Van Leuven, F., & Vassar, R. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-16 · Cited by 85
“Pyramidal neurons, which require large amounts of cellular energy, are the most vulnerable to mitochondrial dysfunction [6].”
BackgroundAkram, A., Christoffel, D. J., Rocher, A. B., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Herrmann, F. R., Haroutunian, V. H., Giannakopoulos, P., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.007 · Cited by 90
“In the context of the possible disconnection of corticocortical pathways in AD [30,32,48], dendritic spine pathology is thought to be secondary to abnormal afferent innervation [20,63,65,81].”
BackgroundSelf-citationHof, P. R., Bussière, T., Gold, G., Kövari, E., Giannakopoulos, P., Bouras, C., Perl, D. P., & Morrison, J. H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.55 · Cited by 85
Self-citationHof, P. R., Duan, H., Page, T. L., Einstein, M., Wicinski, B. A., He, Y., ERWIN, J. M., & Morrison, J. H. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03345-5 · Cited by 96
Self-citationBouras, C., Kövari, E., Herrmann, F. R., Rivara, C.-B., Bailey, T. L., von Gunten, A., Hof, P. R., & Giannakopoulos, P. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000203077.53080.2c · Cited by 84
Self-citationMa, P. M. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970519)381:4<411::aid-cne2>3.0.co;2-5 · Cited by 100
Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide
Buée, L., Ding, W., Delacourte, A., & Fillit, H. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)91706-x · Cited by 82
ROCKENSTEIN, E., CREWS, L., & MASLIAH, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.013 · Cited by 65
Hayes, T. L., & Lewis, D. A. (1992) · Cerebral Cortex · doi:10.1093/cercor/2.1.56 · Cited by 80
Giannakopoulos, P., Silhol, S., Jallageas, V., Mallet, J. J., Bons, N., Bouras, C., & Delaère, P. (1997) · Acta Neuropathologica · doi:10.1007/s004010050684 · Cited by 81
“The strong positive correlation between the densities of tau protein-immunoreactive structures in all neocortical areas in old mouse lemurs parallels previous observations in humans, postulating that damage of selective corticocortical projections may represent a central event in brain aging [18, 27, 28 , 36, 44, 50].”
BackgroundResultGiannakopoulos, P., Hof, P. R., Giannakopoulos, A.-S., Herrmann, F. R., Michel, J.-P., & Bouras, C. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540360028012 · Cited by 79
Self-citationHof, P. R., Perl, D. P., Loerzel, A. J., & Morrison, J. H. (1991) · Brain Research · doi:10.1016/0006-8993(91)91467-f · Cited by 77
Self-citationDuan, H., Wearne, S. L., Morrison, J. H., & Hof, P. R. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00305-6 · Cited by 85
“It is notable that this particular attribute may also render the homologous neurons vulnerable to degeneration in humans with Alzheimer's disease (Hof et al., 1990; Hof and Morrison, 1990; Morrison and Hof, 1997).”
InfluentialSelf-citationBickford, M., Guido, W., & Godwin, D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06549.1998 · Cited by 74
“Other reported changes in neurofilaments, resulting from neurological disorders and after a variety of experimental conditions, indicate the dynamic nature of the neuronal cytoskeleton (Sternberger et al., 1985; Troncoso et al., 1986; Hof and Morrison, 1990; Hof et al., 1990; Vickers et al., 1992; Duong and Gallagher,…”
BackgroundInfluentialNeuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
Wirths, O., & Zampar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218144 · Cited by 75
“Neuron loss is a basic and fundamental feature in the pathogenesis of AD [18,19], starting already at preclinical stages when the neuropathological hallmarks are not yet present [20].”
BackgroundEarly Failure of the Default‐Mode Network and the Pathogenesis of Alzheimer's Disease
Simic, G., Babic, M., Borovecki, F., & Hof, P. R. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12260 · Cited by 75
Self-citationNeural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease
von Gunten, A., Bouras, C., Kövari, E., Giannakopoulos, P., & Hof, P. R. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.003 · Cited by 75
Self-citationSingle domain amnestic MCI: A multiple cognitive domains fMRI investigation
Lenzi, A., Serra, L., Perri, R., Pantano, P., Lenzi, G. L., Paulesu, E., Caltagirone, C., Bozzali, M., & Macaluso, E. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.09.006 · Cited by 82
Ward, M. E., Gelfand, J. M., Lui, L., Ou, Y., Green, A. J., Stone, K., Pedula, K. L., Cummings, S. R., & Yaffe, K. (2018) · Annals of Neurology · doi:10.1002/ana.25196 · Cited by 71
Immunolocalization of sodium channel isoform NaCh6 in the nervous system
Krzemien, D. M., Schaller, K. L., Levinson, S. R., & Caldwell, J. H. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000424)420:1<70::aid-cne5>3.0.co;2-p · Cited by 121
Self-citationAn Anatomic Substrate for Visual Disconnection in Alzheimer's Diseasea
MORRISON, J. H., HOF, P. R., & BOURAS, C. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00187.x · Cited by 70
Self-citationVickers, J., Morrison, J., Friedrich, V., Elder, G., Perl, D., Katz, R., & Lazzarini, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05603.1994 · Cited by 68
Self-citationPassani, L. A., Vonsattel, J. P., Carter, R. E., & Coyle, J. T. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815236 · Cited by 68
Neuronal activity and early neurofibrillary tangles in Alzheimer's disease
Hatanpää, K., Brady, D. R., Stoll, J., Rapoport, S. I., & Chandrasekaran, K. (1996) · Annals of Neurology · doi:10.1002/ana.410400310 · Cited by 67
Neurofilament triplet proteins are restricted to a subset of neurons in the rat neocortex
Kirkcaldie, M., Dickson, T. C., King, C., Grasby, D. J., Riederer, B. M., & Vickers, J. C. (2002) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(02)00043-1 · Cited by 67
Unger, J. W., & Lange, W. (1992) · Acta Neuropathologica · doi:10.1007/bf00299414 · Cited by 68
Alzheimer's disease-related synapse loss in the cingulate cortex
Scheff, S. W., & Price, D. A. (2001) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2001-3509 · Cited by 66
“Historically, motor and primary sensory areas are one of the last areas to be affected in AD while neocortical association areas are affected early in the course of the disease [1,4,8,23,28– 31, 41 The present data supports the idea of a disruption of corticocortical association circuitry.”
Saleem, K. S., Avram, A., Glen, D., Yen, C. C., Ye, F. Q., Komlosh, M. E., & Basser, P. J. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118759 · Cited by 79
Somal size of prefrontal cortical pyramidal neurons in schizophrenia
Pierri, J. N., Volk, C. L. E., Auh, S., Sampson, A. R., & Lewis, D. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00294-4 · Cited by 67
Buée, L., Hof, P. R., Roberts, D. D., Delacourte, A., Morrison, J. H., & Fillit, H. M. (1992) · PubMed · Cited by 74
Self-citationKurylo, D. D., Corkin, S., Rizzo, J. F., III, & Growdon, J. H. (1996) · Neuropsychology · doi:10.1037//0894-4105.10.1.74 · Cited by 65
“Cases have been reported in which visual dysfunction specific to either the ventral or dorsal processing streams reflected specific neuropathological changes in each of these cortical regions (Hof & Bouras, 1991; Hof et al., 1989, 1990).”
Hof, P. R., Nimchinsky, E. A., Buée‐Scherrer, V., Buée, L., Nasrallah, J., Hottinger, A. F., Purohit, D. P., Loerzel, A. J., Steele, J. C., Delacourte, A., et al. (1994) · Acta Neuropathologica · doi:10.1007/bf00389490 · Cited by 67
“the regional and laminar distribution of SP and NFT in the neocortex and hippocampal formation of Alzheimer's disease (AD) cases have suggested that there is a strong correlation between the distribution of SP and NFT and that of the neurons furnishing long corticocortical projections [ 23 , 33, 35, 37, 41].”
BackgroundResultInfluentialSelf-citationKochunov, P., Ganjgahi, H., Winkler, A. M., Kelly, S., Shukla, D. K., Du, X. M., Jahanshad, N., Rowland, L. M., Sampath, H., Patel, B., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23336 · Cited by 67
“The oligodendrocytes of the associative WM tracts also have slower rates of myelin repair [Hof et al., 1990; Wakana et al., 2004].”
BackgroundGiannakopoulos, P., Hof, P. R., Surini, M., Michel, J., & Bouras, C. (1993) · Acta Neuropathologica · doi:10.1007/bf00334669 · Cited by 66
“5 years) had much lower neocortical NFTdensities than those reported in younger patients [1, 15-17, 21, 26, 31, 34].”
BackgroundResultSelf-citationDelatour, B., Blanchard, V, Pradier, L., & Duyckaerts, C. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.008 · Cited by 60
“According to another hypothesis, selective vulnerability of neural pathways is related to the content of neurofilaments and calcium-binding proteins in the sensitive neurons (Hof et al., 1990; Morrison et al., 1998) or to the degree of axon myelination (Braak et al.”
BackgroundPetanjek, Z., Sedmak, D., Džaja, D., Hladnik, A., Rašin, M. R., & Jovanov-Milosevic, N. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00122 · Cited by 59
Wakabayashi, K., Hansen, L. A., & Masliah, E. (1995) · Acta Neuropathologica · doi:10.1007/bf00307643 · Cited by 66
“Previous studies have revealed that the major loss of neurons in the AD neocortex occur among larger pyramidal cells [17, 23 , 44].”
BackgroundMethodResultInfluentialLaw, A. J., & Harrison, P. J. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00075-x · Cited by 65
“These neurons have a similar distribution in human brain and, of note, are highly susceptible to Alzheimer’s disease (Morrison et al., 1987; Hof et al., 1990).”
BackgroundSavaskan, E., Müller-Spahn, F., Olivieri, G., Bruttel, S., Otten, U., Rosenberg, C., Hulette, C., & Hock, C. (2000) · European Neurology · doi:10.1159/000008229 · Cited by 58
“In our series, the pyramidal neurons of cortical layers III and V showed the most striking reduction in trk A immunoreactivity in AD. A subset of pyramidal neurons in layers III and V, where the presence of neuropathological markers of AD such as neurofibrillary tangle formation predominates, have been described to be…”
BackgroundHemispheric asymmetry in the fusiform gyrus distinguishes Homo sapiens from chimpanzees
Chance, S. A., Sawyer, E. K., Clover, L. M., Wicinski, B. A., Hof, P. R., & Crow, T. J. (2012) · Brain Structure and Function · doi:10.1007/s00429-012-0464-8 · Cited by 64
“2011) may be related to the observation here that SMI-32 immunohistochemistry frequently stained multiple neurons vertically within the same minicolumn and SMI-32immunoreactive neurons are thought to be selectively vulnerable to Alzheimer’s disease (Hof et al. 1990; Morrison et al. 1987).”
BackgroundSelf-citationNeocortical Disconnectivity Disrupts Sensory Integration in Alzheimer's Disease.
Festa, E. K., Insler, R. Z., Salmon, D. P., Paxton, J. L., Hamilton, J. M., & Heindel, W. C. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.6.728 · Cited by 61
Sullivan, E. V., Shear, P. K., Mathalon, D. H., Lim, K. O., Yesavage, J. A., Tinklenberg, J. R., & Pfefferbaum, A. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540040021009 · Cited by 55
Areas of cat auditory cortex as defined by neurofilament proteins expressing SMI-32
Mellott, J. G., der Gucht, E. V., Lee, C. C., Carrasco, A. E., Winer, J. A., & Lomber, S. G. (2010) · Hearing Research · doi:10.1016/j.heares.2010.04.003 · Cited by 54
“Assuming a high correlation between function and SMI-32 affinity (Hof et al., 1990; Hof and Morrison, 1990) would help explain why discerning fAES borders proved more difficult to define.”
BackgroundPDGF is associated with neuronal and glial alterations of Alzheimer's disease
Masliah, E., Mallory, M., Alford, M., Deteresa, R., & Saitoh, T. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00050-o · Cited by 61
Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
Lazeyras, F., Charles, H., Tupler, L., Erickson, R., Boyko, O., & Krishnan, K. (1998) · Psychiatry Research · doi:10.1016/s0925-4927(98)00010-9 · Cited by 52
Benzing, W. C., & Mufson, E. J. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90021-7 · Cited by 56
Entorhinal cortical defects in Tg2576 mice are present as early as 2–4 months of age
Duffy, Á. M., Morales-Corraliza, J., Bermudez-Hernandez, K. M., Schaner, M. J., Magagna-Poveda, A., Mathews, P. M., & Scharfman, H. E. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.001 · Cited by 52
In vivo imaging of axonal transport using MRI: aging and Alzheimer’s disease
Minoshima, S., & Cross, D. J. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0707-8 · Cited by 56
Marco, P., de Sola, R. G., y Cajal, S. R., & DeFelipe, J. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00090-7 · Cited by 65
Vermersch, P., Frigard, B., & Delacourte, A. (1992) · Acta Neuropathologica · doi:10.1007/bf00304633 · Cited by 56
Heyer, D. B., Wilbers, R., Galakhova, A. A., Hartsema, E. A., Braak, S., Hunt, S., Verhoog, M. B., Muijtjens, M. L., Mertens, E. J., Idema, S., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab330 · Cited by 49
Cantero, J. L., Záborszky, L., & Atienza, M. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw195 · Cited by 60
Royall, D. R., & Polk, M. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb01022.x · Cited by 49
Dickson, T. C., Chuckowree, J. A., Chuah, M. I., West, A. K., & Vickers, J. C. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.001 · Cited by 61
“Importantly, in human, it is these cells that appear to be selectively vulnerable to neurofibrillary tangle formation (Vickers et al., 1992, 1994) and degeneration (Hof and Morrison, 1990; Hof et al., 1990) in AD.”
BackgroundHof, P. R., Glezer, I. I., Archin, N. M., Janssen, W. G. M., Morgane, P. J., & Morrison, J. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90180-f · Cited by 48
Self-citationPhipps, A. J., Vickers, J. C., Taberlay, P. C., & Woodhouse, A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.003 · Cited by 46
Neurofilament-Immunoreactive Neurons in Alzheimer's Disease and Dementia with Lewy Bodies
Shepherd, C. E., McCann, H., Thiel, E., & Halliday, G. M. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0469 · Cited by 34
Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease
Joyce, J. N., Myers, A., & Gurevich, E. V. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01005-6 · Cited by 52
Passani, L. A., Vonsattel, J. P., & Coyle, J. T. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00784-1 · Cited by 50
Cellular and Systems Neuroanatomical Changes in Alzheimer's Disease
Hoesen, G. W. V., & Solodkin, A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44399.x · Cited by 50
Stein, D. J., Buchsbaum, M. S., Hof, P. R., Siegel, B. V., Jr., & Shihabuddin, L. (1997) · Neuropsychobiology · doi:10.1159/000026471 · Cited by 46
Self-citationRegulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis
Thal, D. R., Gawor, K., & Moonen, S. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02722-0 · Cited by 51
“An interesting feature of neurodegenerative diseases is the selective vulnerability of distinct neurons to specific cell death pathways defined by their anatomical region [50, 100, 101, 218, 219].”
Consens, M. E., Chen, Y., Menon, V., Wang, Y., Schneider, J. A., De Jager, P. L., Bennett, D. A., Tripathy, S. J., & Felsky, D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.903175 · Cited by 44
Thangavel, R., Sahu, S. K., Hoesen, G. W. V., & Zaheer, A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.037 · Cited by 44
Human IMR‐32 neuroblastoma cells as a model cell line in Alzheimer's disease research
Neill, D., Hughes, D., Edwardson, J. A., RIMA, B. K., & Allsop, D. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390415 · Cited by 49
Hof, P. R., Charpiot, A., Delacourte, A., Buée, L., Purohit, D. P., Perl, D. P., & Bouras, C. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90846-y · Cited by 47
Self-citationHof, P. R., Perl, D. P., Loerzel, A. J., Steele, J. C., & Morrison, J. H. (1994) · Brain Research · doi:10.1016/0006-8993(94)90212-7 · Cited by 43
Self-citationAcheson, A., Wijtenburg, S. A., Rowland, L. M., Winkler, A. M., Gaston, F. E., Mathias, C. W., Fox, P. T., Lovallo, W. R., Wright, S. N., Hong, L. E., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22559 · Cited by 45
“The former type of oligodendrocytes produce far fewer myelin layers per axon (less myelin) and have reduced rates of myelin turn over and slower rates of myelin repair than the glia located in the primary sensory and motor tracts [Hof et al., 1990; Lamantia and Rakic, 1990; Wakana et al., 2004].”
Wijtenburg, S. A., McGuire, S., Rowland, L. M., Sherman, P. M., Lancaster, J. L., Tate, D. F., Hardies, L. J., Patel, B., Glahn, D. C., Hong, L. E., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.10.014 · Cited by 46
“…in normal aging (Kochunov et al., 2012; Moseley, 2002; Sullivan et al., 2001) because the oligodendrocytes that myelinate this tract have reduced rates (per axonal-segment) of myelin production and repair (Hof et al., 1990) and are highly susceptible to metabolic damage (Bartzokis et al., 2004).”
BackgroundBlood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
Šimić, G., Španić, E., Horvat, L. L., & Hof, P. R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.003 · Cited by 41
Self-citationUbiquitin-positive achromatic neurons in corticobasal degeneration
Halliday, G. M., Davies, L., McRitchie, D. A., Cartwright, H., Pamphlett, R., & Morris, J. G. (1995) · Acta Neuropathologica · doi:10.1007/bf00294461 · Cited by 40
“There have been several studies demonstrating that these achromatic neurons stain immunohistochemically with phosphorylated neurofilament markers [4, 9, 18, 25, 32, 34], similar to many non-ballooned cortical pyramidal neurons in Alzheimer's disease [ 13 , 33].”
BackgroundBlood pressure and cerebral white matter share common genetic factors in Mexican Americans
Kochunov, P., Glahn, D. C., Lancaster, J., Winkler, A., Karlsgodt, K., Olvera, R. L., Curran, J. E., Carless, M. A., Dyer, T. D., Almasy, L., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.162206 · Cited by 38
Fernandez-Martos, C. M., King, A. E., Atkinson, R. A. K., Woodhouse, A., & Vickers, J. C. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.003 · Cited by 38
“It has previously been demonstrated that NF triplet proteins containing cortical neurons are selectively vulnerable to tangle formation and degeneration in AD (Hof et al., 1990; Hof and Morrison, 1990, 1991; Mitew et al., 2013b; Morrison et al., 1987; Vickers and Costa, 1992; Vickers et al., 1992b, 1994) and that NFco…”
BackgroundLemmens, M. A. M., Sierksma, A. S. R., Rutten, B. P. F., Dennissen, F., Steinbusch, H. W. M., Lucassen, P. J., & Schmitz, C. (2011) · Brain Structure and Function · doi:10.1007/s00429-011-0305-1 · Cited by 37
Genetically altered transgenic models of Alzheimer’s disease
Masliah, E., & Rockenstein, E. M. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_20 · Cited by 41
Differential vulnerability, connectivity, and cell typology
Morrison, J. H. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90021-3 · Cited by 36
Self-citationHof, P. R., Bouras, C., & Morrison, J. H. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_8 · Cited by 38
Self-citationChen, Q., Yoshida, H., Schubert, D., Maher, P. A., Mallory, M. E., & Masliah, E. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63005-2 · Cited by 37
Microglia changes associated to Alzheimer's disease pathology in aged chimpanzees
Edler, M. K., Sherwood, C. C., Meindl, R. S., Munger, E. L., Hopkins, W. D., Ely, J. J., Erwin, J. M., Perl, D. P., Mufson, E. J., Hof, P. R., et al. (2018) · Journal of Comparative Neurology · doi:10.1002/cne.24484 · Cited by 34
Self-citation
Metadata
- Authors
- Hof, P. R., Morrison, J. H., & Cox, K.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of California San Diego (US)
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 1990-11
- Volume
- 301
- Issue
- 1
- Pages
- 44-54
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2049691406
- Cited by
- 365
- References
- 76
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 13 · 2023: 9 · 2022: 8 · 2021: 18 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 10 · 2015: 8 · 2014: 8 · 2013: 4 · 2012: 2
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Comparative Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 05138, P50AG005138, AG-06647)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, pyramidal neurons, neurofilament proteins, neuronal vulnerability, superior frontal cortex, inferior temporal cortex, neurofibrillary tangles, neuronal loss, corticocortical connections
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Antibodies, Monoclonal, Cerebral Cortex, Dendrites, Frontal Lobe, Humans, Immunohistochemistry, Intermediate Filament Proteins, Neurons, Occipital Lobe, Pyramidal Tracts, Temporal Lobe, Neurofilament Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.